GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genomma Lab Internacional SAB de CV (OTCPK:GNMLF) » Definitions » EV-to-FCF

Genomma Lab InternacionalB de CV (Genomma Lab InternacionalB de CV) EV-to-FCF : 12.22 (As of May. 08, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Genomma Lab InternacionalB de CV EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Genomma Lab InternacionalB de CV's Enterprise Value is $1,239.8 Mil. Genomma Lab InternacionalB de CV's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was $101.4 Mil. Therefore, Genomma Lab InternacionalB de CV's EV-to-FCF for today is 12.22.

The historical rank and industry rank for Genomma Lab InternacionalB de CV's EV-to-FCF or its related term are showing as below:

GNMLF' s EV-to-FCF Range Over the Past 10 Years
Min: -47.4   Med: 17.51   Max: 248.46
Current: 12

During the past 13 years, the highest EV-to-FCF of Genomma Lab InternacionalB de CV was 248.46. The lowest was -47.40. And the median was 17.51.

GNMLF's EV-to-FCF is ranked better than
74.56% of 507 companies
in the Drug Manufacturers industry
Industry Median: 23.62 vs GNMLF: 12.00

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-08), Genomma Lab InternacionalB de CV's stock price is $0.92. Genomma Lab InternacionalB de CV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was $0.064. Therefore, Genomma Lab InternacionalB de CV's PE Ratio for today is 14.38.


Genomma Lab InternacionalB de CV EV-to-FCF Historical Data

The historical data trend for Genomma Lab InternacionalB de CV's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genomma Lab InternacionalB de CV EV-to-FCF Chart

Genomma Lab InternacionalB de CV Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 24.70 13.83 20.84 10.42 8.34

Genomma Lab InternacionalB de CV Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.21 11.53 9.45 8.34 11.44

Competitive Comparison of Genomma Lab InternacionalB de CV's EV-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Genomma Lab InternacionalB de CV's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genomma Lab InternacionalB de CV's EV-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Genomma Lab InternacionalB de CV's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Genomma Lab InternacionalB de CV's EV-to-FCF falls into.



Genomma Lab InternacionalB de CV EV-to-FCF Calculation

Genomma Lab InternacionalB de CV's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1239.765/101.44
=12.22

Genomma Lab InternacionalB de CV's current Enterprise Value is $1,239.8 Mil.
Genomma Lab InternacionalB de CV's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $101.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genomma Lab InternacionalB de CV  (OTCPK:GNMLF) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Genomma Lab InternacionalB de CV's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.92/0.064
=14.38

Genomma Lab InternacionalB de CV's share price for today is $0.92.
Genomma Lab InternacionalB de CV's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.064.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Genomma Lab InternacionalB de CV EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Genomma Lab InternacionalB de CV's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Genomma Lab InternacionalB de CV (Genomma Lab InternacionalB de CV) Business Description

Traded in Other Exchanges
Address
Avenida Antonio Dovalí Jaime, Number 70, Tower C, Floor 2, Office A. Colonia Santa Fe, Del. Alvaro Obregon, Mexico, MEX, MEX, CP 01210
Genomma Lab Internacional SAB de CV is a specialty and generic drug manufacturer. The company's stated goal is to improve and preserve the health and well-being of people through innovative, safe, and effective products. Genomma operates a wide variety of brands to serve different consumer needs, including pregnancy, pain medication, and deodorant. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Genomma Lab InternacionalB de CV (Genomma Lab InternacionalB de CV) Headlines